Healthcare Sector Portfolio Overlap
Shared Healthcare sector holdings among 68 institutional investors and superinvestors tracked by InsiderSet based on the latest publicly available SEC Form 13F filings for the quarter ended June 30, 2026.
This page analyzes overlapping Healthcare sector positions across major hedge funds, asset managers, and long-term institutional investors to identify consensus smart money holdings, shared portfolio exposure, and high-conviction investment themes.
Investors can compare pairwise portfolio overlap, explore stocks held by multiple institutional investors, analyze ownership concentration trends, and identify the most widely owned Healthcare sector companies among leading investment firms.
Consensus Healthcare Holdings
Stocks in Healthcare held by two or more tracked superinvestors (ranked by number of filers, then combined reported value).
| Stock | Superinvestors | Combined reported value |
|---|---|---|
| UNH UnitedHealth Group Incorporated | 20 | $7.41B |
| JNJ Johnson & Johnson | 16 | $574.68M |
| ELV Elevance Health, Inc. | 13 | $3.41B |
| DHR Danaher Corporation | 13 | $3.06B |
| PFE Pfizer, Inc. | 13 | $362.95M |
| LLY Eli Lilly and Company | 12 | $2.37B |
| ABT Abbott Laboratories | 12 | $387.47M |
| MRK Merck & Company, Inc. | 12 | $255.70M |
| CVS CVS Health Corporation | 11 | $7.19B |
| VEEV Veeva Systems Inc. | 11 | $351.04M |
| TMO Thermo Fisher Scientific Inc | 10 | $3.69B |
| ABBV AbbVie Inc. | 10 | $78.79M |
| SYK Stryker Corporation | 9 | $2.08B |
| BMY Bristol-Myers Squibb Company | 9 | $1.05B |
| CI The Cigna Group | 8 | $3.74B |
| WAT Waters Corporation | 8 | $2.31B |
| IDXX IDEXX Laboratories, Inc. | 8 | $1.12B |
| MEDP Medpace Holdings, Inc. | 8 | $633.59M |
| BDX Becton, Dickinson and Company | 7 | $2.96B |
| BAX Baxter International Inc. | 7 | $2.95B |
| GEHC GE HealthCare Technologies Inc. | 7 | $2.69B |
| GSK GSK plc | 7 | $2.55B |
| ZBH Zimmer Biomet Holdings, Inc. | 7 | $2.22B |
| ISRG Intuitive Surgical, Inc. | 7 | $513.46M |
| ZTS Zoetis Inc. | 7 | $370.76M |
| NVS Novartis AG | 7 | $259.92M |
| BSX Boston Scientific Corporation | 7 | $190.30M |
| REGN Regeneron Pharmaceuticals, Inc. | 6 | $3.37B |
| GILD Gilead Sciences, Inc. | 6 | $3.31B |
| HCA HCA Healthcare, Inc. | 6 | $1.33B |
| ALGN Align Technology, Inc. | 6 | $411.71M |
| NVST Envista Holdings Corporation | 6 | $377.21M |
| NTRA Natera, Inc. | 6 | $318.34M |
| AMGN Amgen Inc. | 6 | $130.76M |
| XRAY DENTSPLY SIRONA Inc. | 6 | $120.54M |
| HUM Humana Inc. | 5 | $7.63B |
| AVTR Avantor, Inc. | 5 | $1.53B |
| HLN Haleon plc | 5 | $1.44B |
| BMRN BioMarin Pharmaceutical Inc. | 5 | $1.32B |
| NVO Novo Nordisk A/S | 5 | $1.21B |
Highest Healthcare Portfolio Overlap (Pairs)
Top superinvestor pairs ranked by overlap score within Healthcare only (shared symbols and reported values in this sector).